VISTAGEN THERAPEUTICS, INC. Other Accrued Liabilities, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Other Accrued Liabilities, Current of $53.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-06-15
- 2026-03-31: Other Accrued Liabilities, Current $53.00K.
- 2025-03-31: Other Accrued Liabilities, Current $9.00K.
- 2024-03-31: Other Accrued Liabilities, Current $17.00K.
- 2023-06-30: Other Accrued Liabilities, Current $10.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $53.00K 10-K · filed 2026-06-15 | |
| 2025-03-31 | $9.00K 10-K · filed 2026-06-15 | |
| 2024-03-31 | $17.00K 10-K · filed 2025-06-17 | |
| 2023-06-30 | $10.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $9.00K 10-K · filed 2024-06-11 | $0.00 10-K · filed 2023-06-28 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $1.20K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.40K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $32.70K 10-K · filed 2023-06-28 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $62.60K 10-Q · filed 2021-11-10 | |
| 2021-03-31 | $27.80K 10-K · filed 2022-06-23 | |
| 2020-12-31 | $5.50K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $16.40K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $20.70K 10-Q · filed 2021-08-12 | $16.10K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $22.70K 10-K · filed 2021-06-29 | |
| 2019-12-31 | $7.90K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $7.20K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $7.70K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $6.70K 10-K · filed 2020-06-29 | |
| 2018-12-31 | $8.80K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $5.50K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $3.50K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.70K 10-K · filed 2019-06-25 | |
| 2017-12-31 | $3.10K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $10.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $67.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.60K 10-K · filed 2018-06-26 | |
| 2016-12-31 | $8.80K 10-Q · filed 2017-02-13 | |
| 2016-06-30 | $5.00K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $0.00 10-K · filed 2017-06-29 | |
| 2015-12-31 | $1.00K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $19.40K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.50K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $2.00K 10-K · filed 2016-06-24 | |
| 2014-09-30 | $13.30K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $810.20K 10-Q · filed 2014-08-12 | |
| 2013-06-30 | $12.30K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $625.60K 10-Q · filed 2014-08-12 | $30.80K 10-K · filed 2013-07-18 |
| 2012-12-31 | $10.90K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $38.20K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $67.30K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $27.50K 10-K · filed 2013-07-18 | $32.50K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |